Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
HR (95% CI) | p-value | Model | HR (95% CI) | p-value | |
Age | 0.996 (0.970–1.023) | 0.783 | Base model | ||
Male | 0.638 (0.281–1.446) | 0.282 | LGE% | 1.081 (1.044–1.120) | < 0.001 |
Known AF | 3.299 (1.425–7.637) | 0.005 | Known AF | 2.421 (0.903–6.490) | 0.079 |
Unexplained syncope | 0.926 (0.274–3.131) | 0.901 | LVEF | 1.006 (0.951–1.064) | 0.844 |
Family history of SCD | 0.711 (0.236–2.682) | 0.711 | Left atrial size | 1.036 (0.974–1.102) | 0.259 |
NSVT | 2.134 (0.903–5.042) | 0.084 | NSVT | 1.121 (0.441–2.848) | 0.810 |
Left atrial size | 1.060 (1.016–1.105) | 0.007 | With HCM Risk-SCD | ||
LVOTO | 1.004 (0.992–1.015) | 0.516 | HCM Risk-SCD | 0.970 (0.866–1.086) | 0.596 |
LVM > 30 mm | 1.194 (0.516–2.763) | 0.679 | LGE% | 1.087 (1.053–1.123) | < 0.001 |
LVMi | 1.003 (0.995–1.011) | 0.478 | With ACCF/AHA | ||
LVEF | 0.951 (0.903–1.002) | 0.057 | ‘ICD not recommended’ | reference | – |
LGE% | 1.083 (1.052–1.116) | < 0.001 | ‘ICD can be useful’ | 1.971 (0.664–5.847) | 0.221 |
HCM Risk-SCD | 1.034 (0.944–1.132) | 0.476 | ‘ICD reasonable’ | 0.966 (0.354–2.636) | 0.946 |
ACCF/AHA | LGE% | 1.082 (1.049–1.117) | < 0.001 | ||
‘ICD not recommended’ | reference | – | |||
‘ICD can be useful’ | 3.053 (1.058–8.809) | 0.039 | |||
‘ICD reasonable’ | 1.698 (0.652–4.422) | 0.278 |